This chart collection explores how health spending is expected to grow in coming years, with a look at growth in prescription drug spending, out-of-pocket spending, and related trends.
Category: Kaiser Family Foundation
KFF Health News, NPR, and CBS News Win Loeb Award for Series on Medical Debt in America
KFF Health News won the 2023 Loeb Award in the personal finance and consumer reporting category for its in-depth coverage of consumer medical debt in its “Diagnosis: Debt” series. In partnership with NPR and CBS News, KFF Health News examined the stori…
Consumer Survey Highlights Problems with Denied Health Insurance Claims
This Data Note includes major findings from the KFF Consumer Survey on consumer experiences with claim denials. Among those who used the most health care over the past year, 27% experienced a denied claim. More consumers with private insurance experie…
Private Insurer Payments for Telehealth and In-Person Claims During the Pandemic
This analysis of 2021 claims data finds that while telehealth use remained high in the second year of the COVID-19 pandemic, the shift toward virtual physician and mental health care did not materially affect how much insurers paid for each patient enc…
How Medicare’s New Drug Price Negotiation Program Could Expand Access to Selected Drugs
This brief examines how Part D enrollees’ access to and utilization of the first set of 10 selected drugs could be affected by the new Part D coverage and formulary requirements for selected drugs established by the Inflation Reduction Act and in CMS g…
What are the recent and forecasted trends in prescription drug spending?
This slideshow looks at past, present and future trends in prescription drug spending with a focus on the role of specialty drugs.
The 4 Arguments You Will Hear Against Drug Price Negotiation
As the Biden administration begins the process of negotiation drug prices for Medicare as authorized in the Inflation Reduction Act, KFF’s Larry Levitt probes some of the arguments against it and the policy and political implications of the debate in t…
Will Where You Live Determine Access and Coverage of Emerging Anti-Obesity Drugs?
The U.S. Midwest and South regions have higher average obesity rates among adults. What does this mean for access and coverage of prescription drugs for weight loss?
Understanding Mergers Between Hospitals and Health Systems in Different Markets
This brief explains the role and implications of cross-market mergers between hospitals and health systems that operate in different regions and describes the approaches that government antitrust agencies have taken in reviewing these types of transact…
Drugs Used for Weight Loss Could Cost Americans Much More Than People in Peer Countries
In addition to having the highest obesity rates, the U.S is currently facing significantly higher prices for several major drugs used for weight loss and other health needs, according to a new KFF analysis of the list prices for semaglutide and tirzepa…
